| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
3 companies
Pharis Mohideen is Chief Medical Officer at DBVT and has filed Form 4s across 3 companies. Pharis Mohideen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.8M at current prices.
Historically, Pharis Mohideen's trades have earned a below-average insider score of 47/100 across 15 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -45.1%.
The biggest single holding is DBVT (~$1.5M) as Chief Medical Officer. The DBVT filings lean toward selling, a net 20,705 shares.
Pharis Mohideen has 16 Form 4 filings on record from December 2018 to July 2026, across 3 companies: Chief Medical Officer at Dbv Technologies (DBVTF), 2026; Chief Medical Officer at DBV Technologies (DBVT), 2021–2026; Chief Medical Officer at Tempest Therapeutics (TPST), 2018–2019.
The 33 reported transactions were 16 open-market sales, 10 option or other derivative awards and 7 stock awards.
Counted by filing, the open-market trades come to no purchases and 12 sales worth about $45K.
The largest open-market sale was 8,120 shares of DBVT at an average $2.86 on November 21, 2025, about $23K.
None of the 12 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | DBVTF Dbv Technologies | Chief Medical Officer | Sell | 464 | $2.70 | $1,252.80 | -0.3% | - | - | |
| Jan 29, 2026 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 534 | $4.86 | $2,595.24 | -0.4% | -11.6% | - | |
| Nov 21, 2025 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 8,120 | $2.86 | $23,206.96 | -7.4% | +53.2% | - | |
| Jul 29, 2025 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 464 | $2.22 | $1,030.08 | -0.4% | +63.2% | +40.1% | |
| May 22, 2025 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 397 | $1.84 | $730.48 | -0.4% | +11.7% | +107.3% | |
| Jan 30, 2025 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 600 | $0.85 | $510.00 | -0.5% | +111.5% | +407.3% | |
| Nov 25, 2024 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 907 | $0.55 | $503.31 | -0.8% | +64.4% | +418.4% | |
| Nov 21, 2024 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 2,350 | $0.54 | $1,269.00 | -2.1% | +81.9% | +463.4% | |
| Jul 29, 2024 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 1,785 | $0.98 | $1,749.30 | -2.2% | -13.9% | +113.0% | |
| May 24, 2024 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 1,042 | $1.37 | $1,424.76 | -1.3% | -24.5% | +38.0% |